Table 1.
General characteristics of patients hospitalized due to vaccine-related myocardial involvement at the CMR imaging.
| Patient | Age 1 | Sex 2 | Vaccination | History | Medication | Temp 3 | HR 4 | BP 5 | CRP 5 | Adm Hs-TnI 6 | Nadir Hs-TnI 6 | BNP 7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 17 | F | Pfizer/BioNTech | AVNRT | Atenolol | 37.1 | 98 | 110/70 | 2.2 | 439 | 6609 | 73 |
| 2 | 18 | M | Pfizer/BioNTech | RBBB | // | 38.2 | 70 | 120/80 | 4.3 | 8123 | 9897 | 57 |
| 3 | 25 | M | Moderna | // | // | 38 | 57 | 120/70 | 7.3 | 40568 | 12500 | 5 |
| 4 | 16 | F | Moderna | // | // | 37.6 | 77 | 125/65 | 3.5 | 576 | 5703 | 76 |
| 5 | 15 | M | Pfizer/BioNTech | // | // | 38.3 | 78 | 115/67 | 4.5 | 4070 | 6078 | 58 |
| 6 | 14 | M | Pfizer/BioNTech | // | Acetaminophen | 37.7 | 69 | 123/70 | 2.7 | 676 | 5047 | 45 |
Legend: Temperature (Temp); heart rate (HR); blood pressure (BP); c-reactive protein (CRP); admission (Adm); high-sensitive Troponin-I (Hs-TnI); Brain Natriuretic Peptide (BNP); atrioventricular nodal reentrant tachycardia (AVNRT); right bundle branch block (RBBB); upper limit (upl). Footnotes: 1 (years); 2 (M/F); 3 (C°); 3 (bpm); 4 (mmHg); 5 (mg/dL), upl 0.6; 6 (ng/L), range: Females 2–51, males 2–75; 7 (pg/mL), upl 100.